Browse By Cell Line Result Page of OvirusTdb
The total number of records retrieved from this search are 7. Click on ID to see further detail.
IDOV_1765 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration0.001 MOI | In-vitro result100% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1766 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration0.01 MOI | In-vitro result80% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1767 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration0.1 MOI | In-vitro result80% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1768 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration1 MOI | In-vitro result70% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1769 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration5 MOI | In-vitro result50% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1770 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration10 MOI | In-vitro result30% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |
IDOV_1771 | Virus nameParovirus | Virus strainH-1PV | Virus genome typeDNA | Virus familyParoviridae | Virus genome modificationNone | Virus aloneYes | Virus in combination with drug/radiationNo | Immune gene insertion in viral genomeNo | Source of cell lineATCC | Origin of cell lineHuman neuroblastoma cell line | Cell lineBE2-c | Concentration of cell line7.6E+3 cells per well | In-vitro toxicityNA | AssayMTT assay | In-vitro virus concentration50 MOI | In-vitro result20% cell survival | Model organismNo | In-vivo virus concentrationNo | In-vivo toxicityNA | In-vivo resultNo response | Mode of deliveryNA | Pathway inducedCell cycle arrest at G2 phase and induction of apoptosis by virus | Immunogenic effectNA | Clinical trialNA | PMID20087864 |